Melanoma: more answers, more questions

Oncologist. 2013 Jun;18(6):658-60. doi: 10.1634/theoncologist.2013-0212.

Abstract

This issue's series of articles on ipilimumab are placed into the context of current treatment practices in melanoma.

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Drug Synergism*
  • Drug-Related Side Effects and Adverse Reactions / pathology*
  • Female
  • Humans
  • Ipilimumab
  • Male
  • Melanoma / drug therapy*
  • Melanoma / genetics*
  • Melanoma / immunology*
  • Neoplasm Metastasis / drug therapy*
  • Neoplasm Metastasis / immunology*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / immunology*

Substances

  • Antibodies, Monoclonal
  • Ipilimumab
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf